Patent · US Active

Recombinant virus and preparations thereof

US11332719B2 · kind B2 · utility

14Cited by
2References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 14, 2014
Grant dateMay 17, 2022
Priority date
Expiry dateMar 14, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention generally relates to methods and compositions used delivery of gene editing compositions including transcriptional effectors with parvovirus and preferred methods for making same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.